Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved save search
Illumina's planned divestment of GRAIL approved by the European Commission
Published: 2024-04-12 (Crawled : 13:00) - prnewswire.com
ILMN | $124.41 3.46% 3.34% 1.3M
|
Health Technology
|
| O: -1.3%
H: 4.53%
C: -1.5%
approved
Provident Financial Services, Inc. Receives Federal Reserve Board Approval for its Merger with Lakeland Bancorp, Inc.
Published: 2024-04-11 (Crawled : 23:00) - globenewswire.com
PFS | $15.52 2.11% 0.0% 940K
|
Finance
|
| O: 1.18%
H: 3.5%
C: 2.4%
LBAI | $12.86 2.06% 2.02% 420K
|
Finance
|
| O: 0.36%
H: 4.91%
C: 3.84%
reserve approval for financial
NuZee, Inc. Announces NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)
Published: 2024-04-11 (Crawled : 22:00) - prnewswire.com
NUZE | $1.24 -0.09% 7.1K
|
Distribution Services
|
| O: 3.32%
H: 0.0%
C: -4.78%
nasdaq extension
Kiora Pharmaceuticals Receives Grant from Choroideremia Research Foundation to Fund Novel Clinical Trial Endpoints for Inherited Retinal Diseases; Approval Granted to Initiate Clinical Validation Study
Published: 2024-04-11 (Crawled : 17:00) - biospace.com/
KPRX | $0.601 23.92% 19.3% 1.2M
|
Manufacturing
|
| O: 3.23%
H: 0.16%
C: -1.79%
granted approval pharmaceuticals research for grant trial foundation study
FASENRA approved for treatment of children aged 6 to 11 with severe asthma
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 1.47%
H: 1.16%
C: -1.27%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: 3.34%
H: 0.27%
C: -0.62%
children approved treatment for
BBSI Announces Board Approval of Planned Four-For-One Stock Split, Pending Stockholder Approval of an Increase in Authorized Shares of Common Stock
Published: 2024-04-10 (Crawled : 20:00) - globenewswire.com
BBSI | $123.47 0.54% 0.53% 17K
|
Commercial Services
|
| O: 0.93%
H: 0.0%
C: -0.7%
authorized approval
Japanese Ministry of Agriculture Grants New Approval for Broccoli Solutions
Published: 2024-04-10 (Crawled : 17:00) - agrofresh.com
PSMMY | $32.98 -1.02% 8.7K
|
Construction
|
| O: -0.67%
H: 0.0%
C: -1.77%
approval solutions for agriculture grants
Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU400—Modifier Gene Therapy for Broad Retinitis Pigmentosa Indication
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
OCGN | News A | $1.24 0.0% 6.9M
|
Health Technology
|
| O: 2.92%
H: 3.41%
C: 2.27%
ocu400 approval positive for therapy
Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
VVOS | $2.64 -1.12% 35K
|
Health Technology
|
| O: -0.33%
H: 13.91%
C: -8.77%
approval care for medical
Gogo Secures FCC Regulatory Approval for Gogo Galileo Terminals
Published: 2024-04-09 (Crawled : 11:00) - prnewswire.com
GOGO | $8.59 3.25% 3.14% 590K
|
Communications
|
| O: 1.81%
H: 8.04%
C: 3.43%
approval for
Busy Weekend Sees Tumor-Agnostic Win for Enhertu, Another Rejection for Supernus
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: -0.8%
PRGO | $30.49 1.43% 0.0% 1.1M
|
Health Technology
|
| O: 0.96%
H: 1.17%
C: 0.16%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: 0.0%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: 0.09%
H: 0.16%
C: -0.7%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
for
C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor
Published: 2024-04-08 (Crawled : 14:00) - biospace.com/
CCCC | $6.89 0.44% 0.44% 910K
|
Health Technology
|
| O: -1.57%
H: 0.0%
C: 0.0%
cft1946 approved preclinical for therapeutics
ViiV Healthcare announces U.S. FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV
Published: 2024-04-08 (Crawled : 13:30) - biospace.com/
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
fda approval for hiv living
Astrotech Announces Listing to the GSA as an Approved United States Government Vendor
Published: 2024-04-08 (Crawled : 13:00) - globenewswire.com
ASTC | $9.261 2.41% 700
|
Electronic Technology
|
| O: 0.1%
H: 6.9%
C: 6.9%
approved
Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
VERO | $0.787 -6.79% -7.28% 19K
|
Health Technology
|
| O: 1.51%
H: 0.0%
C: -9.59%
approval for max
C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Association for Cancer Research Annual Meeting 2024
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
CCCC | $6.89 0.44% 0.44% 910K
|
Health Technology
|
| O: -1.57%
H: 0.0%
C: 0.0%
cft1946 association approved cancer care research preclinical for meeting therapeutics
FDA Greenlights BMS, J&J CAR-T Therapies for Earlier Multiple Myeloma Treatment
Published: 2024-04-06 (Crawled : 16:20) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
| Email alert
Add to watchlist
fda treatment for car-t
CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of Therapy
Published: 2024-04-06 (Crawled : 04:20) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
| Email alert
Add to watchlist
carvykti fda first approved one treatment for therapy
U.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s Abecma for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma After Two Prior Lines of Therapy
Published: 2024-04-05 (Crawled : 14:00) - biospace.com/
TSVT | $4.63 -0.43% -0.43% 290K
|
|
| O: 7.98%
H: 9.06%
C: -9.06%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: -0.41%
H: 0.51%
C: 0.25%
fda for therapy
Eagle Shareholders Approve Merger With Star Bulk
Published: 2024-04-05 (Crawled : 13:00) - globenewswire.com
SBLK | $23.94 2.18% 2.13% 1M
|
Transportation
|
| O: 1.22%
H: 1.45%
C: -0.87%
EGLE | $62.6 0.0% 2.9M
|
Transportation
|
| O: 0.3%
H: 1.76%
C: -0.52%
star
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.